Posted on Jul 20, 2023
Blockbuster drug Humira finally faces lower-cost rivals
165
4
1
2
2
0
Posted 10 mo ago
Responses: 1
PO1 William "Chip" Nagel
"Blockbuster Arthritis Drug Humira Faces Competition From First Lower-Price Copycat in U.S. Amgen’s Amjevita takes on AbbVie’s top-selling biotech treatment after fights over how long its patents last By Jared S. Hopkins Jan. 31, 2023 6:00 am ET Listen (2 min)"...
"Blockbuster Arthritis Drug Humira Faces Competition From First Lower-Price Copycat in U.S. Amgen’s Amjevita takes on AbbVie’s top-selling biotech treatment after fights over how long its patents last By Jared S. Hopkins Jan. 31, 2023 6:00 am ET Listen (2 min)"...
(2)
(0)
Read This Next